NHT
WST icon

New Hampshire Trust’s West Pharmaceutical WST Stock Holding History

New Hampshire Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-241
Closed -$83.5K – 351
2023
Q1 		$83.5K Buy
+241
New +$70.4K 0.02% 221

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

New Hampshire Trust's WST Position: Q2 2023 in Review

New Hampshire Trust sold out of West Pharmaceutical (WST) in Q2 2023, closing a stake of 241 shares — an estimated $83.5K sold.

New Hampshire Trust first reported a position in WST in Q1 2023 and held it in 1 quarter. The position peaked at $83.5K in Q1 2023. 734 funds tracked by Wall St. Rank hold WST as of Q2 2023.

  • New Hampshire Trust reported no remaining West Pharmaceutical position as of Q2 2023 after selling out during the quarter.
  • New Hampshire Trust sold 241 West Pharmaceutical shares in Q2 2023, an estimated $83.5K.
  • New Hampshire Trust first reported a position in West Pharmaceutical in Q1 2023 and held it in 1 quarter.
  • New Hampshire Trust's West Pharmaceutical position peaked at $83.5K in Q1 2023.
  • 734 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2023.

Based on New Hampshire Trust's 13F filing for Q2 2023, filed 11 Jul 2023.